{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:57:59Z","timestamp":1781301479640,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.arth.2026.05.019","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:03:22Z","timestamp":1779084202000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rates of New-Onset Postoperative Heart Failure Among Type 2 Diabetics Who Use Nonsteroidal Anti-Inflammatory Drugs for Total Hip Arthroplasty"],"prefix":"10.1016","author":[{"given":"Sophia S.","family":"Antonioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden V.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Prinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4882-209X","authenticated-orcid":false,"given":"Farouk","family":"Khury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Schwarzkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Macaulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2026.05.019_bib1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2026.05.019_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2026.05.019_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42836-022-00156-1","article-title":"Epidemiology of total hip arthroplasty: demographics, comorbidities and outcomes","volume":"5","author":"Patel","year":"2023","journal-title":"Arthroplasty"},{"key":"10.1016\/j.arth.2026.05.019_bib4","article-title":"Projections and epidemiology of primary hip and knee arthroplasty in medicare patients to 2040-2060","volume":"8","author":"Shichman","year":"2023","journal-title":"JB JS Open Access"},{"key":"10.1016\/j.arth.2026.05.019_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/pop.2015.0181","article-title":"Diabetes 2030: insights from yesterday, today, and future trends","volume":"20","author":"Rowley","year":"2017","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.arth.2026.05.019_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000657","article-title":"New directions in incidence and prevalence of diagnosed diabetes in the USA","volume":"7","author":"Benoit","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.arth.2026.05.019_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.arth.2026.05.019_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-085400","article-title":"Association between diabetes mellitus and total hip arthroplasty outcomes: an observational study using the US National Inpatient Sample","volume":"14","author":"Chandrupatla","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.arth.2026.05.019_bib10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.joca.2022.07.006","article-title":"Time trends in use of non-steroidal anti-inflammatory drugs and opioids one year after total hip arthroplasty due to osteoarthritis during 1996\u20132018: a population-based cohort study of 103,209 patients","volume":"30","author":"Klen\u00f8","year":"2022","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.arth.2026.05.019_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.suc.2014.10.002","article-title":"Postoperative pain control","volume":"95","author":"Lovich-Sapola","year":"2015","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.arth.2026.05.019_bib12","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.jacc.2023.02.027","article-title":"Heart failure following anti-inflammatory medications in patients with type 2 diabetes mellitus","volume":"81","author":"Holt","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.arth.2026.05.019_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1159\/000531604","article-title":"Can nonsteroidal anti-inflammatory drugs lead to first-time heart failure in patients with diabetes mellitus Type-2: is there a link?","volume":"108","author":"Tabassum","year":"2023","journal-title":"Pharmacology"},{"key":"10.1016\/j.arth.2026.05.019_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.EDE.0000034633.74133.C3","article-title":"Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure","volume":"14","author":"Garc\u00eda Rodr\u00edguez","year":"2003","journal-title":"Epidemiol Camb Mass"},{"key":"10.1016\/j.arth.2026.05.019_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.arth.2026.05.019_bib16","article-title":"Meloxicam versus celecoxib for Postoperative Analgesia after total knee arthroplasty: safety, efficacy and cost","volume":"6","author":"Haffar","year":"2022","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"10.1016\/j.arth.2026.05.019_bib17","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/rheumatology\/keg376","article-title":"Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data","volume":"42","author":"Layton","year":"2003","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.arth.2026.05.019_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00002018-200629030-00009","article-title":"Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study","volume":"29","author":"Huang","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.arth.2026.05.019_bib19","first-page":"289","article-title":"Comparison of pre-emptive effect of meloxicam and celecoxcib on post-operative analgesia: a double-blind, randomized clinical trial","volume":"23","author":"Aghadavoudi","year":"2015","journal-title":"Middle East J Anaesthesiol"},{"key":"10.1016\/j.arth.2026.05.019_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.18433\/J3VW2F","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.arth.2026.05.019_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.HYP.0000116221.27079.ea","article-title":"Cyclooxygenases, the kidney, and hypertension","volume":"43","author":"Cheng","year":"2004","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"10.1016\/j.arth.2026.05.019_bib22","doi-asserted-by":"crossref","first-page":"ii9","DOI":"10.1093\/eurjpc\/zwad166","article-title":"Fluid balance in heart failure","volume":"30","author":"Cosentino","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.arth.2026.05.019_bib23","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.arth.2020.05.035","article-title":"The efficacy and safety of nonsteroidal anti-inflammatory drugs in total joint arthroplasty: systematic review and direct meta-analysis","volume":"35","author":"Fillingham","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2026.05.019_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000133","article-title":"Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population","volume":"3","author":"Kim","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.arth.2026.05.019_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/atm.2016.08.57","article-title":"Propensity score method: a non-parametric technique to reduce model dependence","volume":"5","author":"Zhang","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.arth.2026.05.019_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.165.2.161","article-title":"The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus","volume":"165","author":"Sowers","year":"2005","journal-title":"Arch Intern Med"},{"issue":"8 Suppl","key":"10.1016\/j.arth.2026.05.019_bib27","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.jclinepi.2013.01.013","article-title":"Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research","volume":"66","author":"Stuart","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.arth.2026.05.019_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/clc.22502","article-title":"Nonsteroidal anti-inflammatory drugs and risk of incident heart failure: a systematic review and meta-analysis of observational studies","volume":"39","author":"Ungprasert","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.arth.2026.05.019_bib29","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/dc10-0555","volume":"33","author":"Pignone","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arth.2026.05.019_bib30","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.5114\/amsad.2021.105596","article-title":"Aspirin in primary prevention of cardiovascular disease in diabetes","volume":"6","author":"Papazafiropoulou","year":"2021","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"10.1016\/j.arth.2026.05.019_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ehf2.13688","article-title":"Aspirin use is associated with increased risk for incident heart failure: a patient-level pooled analysis","volume":"9","author":"Mujaj","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.arth.2026.05.019_bib32","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3390\/jcm12226969","article-title":"Postoperative complications associated with non-steroidal anti-inflammatory combinations used status-post total hip and knee arthroplasty","volume":"12","author":"Nakata","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.arth.2026.05.019_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2017.11.013","article-title":"Antiplatelet effect of aspirin during 24h in patients with type 2 diabetes without cardiovascular disease","volume":"161","author":"Vernstr\u00f8m","year":"2018","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"10.1016\/j.arth.2026.05.019_bib34","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1998","journal-title":"Inflamm Res"},{"key":"10.1016\/j.arth.2026.05.019_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.160.6.777","article-title":"Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem","volume":"160","author":"Page","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326005097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540326005097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:41:16Z","timestamp":1781300476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540326005097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":34,"alternative-id":["S0883540326005097"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2026.05.019","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of New-Onset Postoperative Heart Failure Among Type 2 Diabetics Who Use Nonsteroidal Anti-Inflammatory Drugs for Total Hip Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2026.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}